
Hodgkin lymphoma is a lymphatic malignancy. The lymphatic system is part of the body's immune system, which fights germs and diseases. Hodgkin lymphoma develops when healthy cells in the lymphatic system mutate and expand out of control.
The lymphatic system contains lymph nodes. They are located throughout the body. Most lymph nodes are in the abdomen, groin, pelvis, chest, underarms, and neck.
The lymphatic system contains the spleen, thymus, tonsils, and bone marrow. Hodgkin lymphoma can affect all these locations and other organs in the body.
Hodgkin lymphoma, formerly known as Hodgkin disease, is one of two primary forms of lymphomas. The other is non-Hodgkin's lymphoma.
Timely treatment of Hodgkin Lymphoma (HL) is essential for improving outcomes and increasing the likelihood of a cure. Early detection and action considerably boost the possibility of complete remission, as HL responds favourably to early-stage treatments such as chemotherapy and radiation.
Delaying treatment can allow cancer to spread, resulting in serious problems such as organ damage and an increased chance of subsequent cancers. As a result, beginning treatment early increases survival chances and reduces long-term health risks.
The most frequent initial symptom of Hodgkin lymphoma is painless enlarged lymph nodes in the neck, underarm, or groin. Additional symptoms include:
There are four classical Hodgkin lymphoma subtypes:
Disease staging assists healthcare providers in determining how advanced the disease is, how quickly it may spread, and which treatments may be most effective. Here are the phases of Hodgkin lymphoma.
Causes
Risk Factors
The following factors can raise the risk of Hodgkin lymphoma:
Complications
Complications of Hodgkin lymphoma (HL) can include:
Here are some preventative tips for Hodgkin Lymphoma (HL):
While these strategies may not ensure prevention, they promote general health and early intervention.
Chemotherapy: This typical Hodgkin lymphoma treatment employs one or more medications to kill or prevent cancer cells from growing. Providers may utilise one or more types of chemotherapies.
Cost Start From USD 600 - USD 700Explore Options
Radiation therapy: This therapy employs high-powered laser beams to kill cancer cells in afflicted lymph nodes or areas of malignant dissemination. It is frequently used with chemotherapy for early-stage Hodgkin lymphoma treatment.
Immunotherapy: This treatment strengthens your immune system, making it more effective in identifying and eliminating cancer cells. Checkpoint inhibitors are a key immunotherapy treatment for Hodgkin lymphoma.
Cost Start From USD 3000 - USD 5000Explore Options
Targeted therapy: It is the employment of medications or other substances to attack cancer cells. This treatment employs laboratory-created antibodies that are linked to chemotherapeutic medicines. They identify and eliminate cancer cells.
Cost Start From USD 8000 - USD 12000Explore Options
Bone Marrow Transplant: A bone marrow transplant, also known as a bone marrow stem cell transplant, involves introducing healthy bone marrow stem cells into the body. These cells restore damaged cells caused by chemotherapy and other treatments. If Hodgkin's lymphoma reappears or does not respond to conventional therapies, a bone marrow transplant may be a viable alternative.
Cost Start From USD 25000 - USD 35000Explore Options
Rehabilitation for Hodgkin Lymphoma (HL) focuses on assisting patients in recovering physically, emotionally, and cognitively during and after therapy. Key rehabilitation options include:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Pune, India
Ruby Hall Clinic located in Pune, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Yashoda Hospital, Malakpet located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Bangalore, India
Aster CMI Hospital located in Bengaluru, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing India:
Yes, Hodgkin lymphoma is very treatable and frequently curable, mainly if detected early. Chemotherapy, radiation therapy, or a combination are commonly used as treatments. Survival rates in India are comparable to global averages, particularly for early-stage diseases.
Chemotherapy, radiation therapy, or a combination are commonly used as treatments. The most popular chemotherapy treatment. Stem cell transplants may be considered in advanced stages or after a recurrence.
In India, patients with Hodgkin lymphoma have a survival rate ranging from 80-90% if discovered early. The prognosis is determined by the stage of the disease, the patient's age, overall health, and the response to treatment.
Hodgkin lymphoma is uncommon compared to other malignancies, such as breast or lung cancer, yet it remains a serious health risk. It is more typically diagnosed in young adults (ages 15 to 40), but it can occur at any age.
Standard treatment side effects include nausea, hair loss, exhaustion, infections, and organ damage caused by chemotherapy or radiation. Long-term follow-up is required to monitor for any residual effects.
Hodgkin lymphoma (HL) treatment is very successful in India, with a 5-year survival rate of 80-90% for early-stage cancer. Early detection and standard therapies such as chemotherapy result in excellent outcomes, particularly in patients under 40. Advanced treatments for relapsed instances, such as stem cell transplants, have increased survival rates.
Yes, continued research and clinical trials are undertaken in India to enhance treatments and patient survival rates. These studies frequently investigate novel chemotherapy regimens, immunotherapy, and targeted therapies. Patients may be allowed to participate in clinical trials for novel medicines.